The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation• Stanford’s AI Designed Bacteriophages: Ushering in the Next Phase in IP Strategy for Phage Companies?• Breathing Engineered Bacteria: A New Approach to Treating Lung Disease• Vedanta Biosciences Secures $60 Million in Funding Ahead of Pivotal Phase 3 Data• Gut fungi may hold the key to treating Asthma worldwide•

Category: Genetically Modified Organisms & Synthetic Biology

CRISPRing the microbiome is just around the corner
Editor's Choice

CRISPRing the microbiome is just around the corner

DEC 10, 2021
Bringing the Transformative Power of Synthetic Biology to Medicine
Biotech Showcase

Bringing the Transformative Power of Synthetic Biology to Medicine

DEC 6, 2021
Synlogic Announces Positive Phase 2 Data Demonstrating Reduction in Plasma Phenylalanine Levels in Patients with Phenylketonuria
Clinical & Manufacturing

Synlogic Announces Positive Phase 2 Data Demonstrating Reduction in Plasma Phenylalanine Levels in Patients with Phenylketonuria

SEP 20, 2021
MD Anderson and SNIPR BIOME collaborate to advance next-generation CRISPR microbiome therapeutics
Finance

MD Anderson and SNIPR BIOME collaborate to advance next-generation CRISPR microbiome therapeutics

SEP 15, 2021
HKU Scientists Harness the naturally abundant CRISPR-Cas system to edit superbugs
Genetically Modified Organisms & Synthetic Biology

HKU Scientists Harness the naturally abundant CRISPR-Cas system to edit superbugs

JUL 26, 2021
Synlogic Enters Research Collaboration with Roche for Development of Novel Therapy to Treat Inflammatory Bowel Disease
Finance

Synlogic Enters Research Collaboration with Roche for Development of Novel Therapy to Treat Inflammatory Bowel Disease

JUN 22, 2021
Beyond synthetic biology, synthetic ecology boosts health by engineering the environment
Genetically Modified Organisms & Synthetic Biology

Beyond synthetic biology, synthetic ecology boosts health by engineering the environment

JUN 21, 2021
Locus Biosciences signs contract with BARDA to advance $144 million precision medicine program to develop LBP-EC01, a crPhage™ product
Finance

Locus Biosciences signs contract with BARDA to advance $144 million precision medicine program to develop LBP-EC01, a crPhage™ product

OCT 1, 2020
Azitra Awarded U.S. Composition of Matter Patent Covering Engineered Bacterial Strains for Treating Skin Conditions
Genetically Modified Organisms & Synthetic Biology

Azitra Awarded U.S. Composition of Matter Patent Covering Engineered Bacterial Strains for Treating Skin Conditions

JUL 13, 2020
Quadram Institute part of consortium using new vaccine delivery systems & synthetic biology to tackle coronavirus
Basic & Discovery Research

Quadram Institute part of consortium using new vaccine delivery systems & synthetic biology to tackle coronavirus

APR 10, 2020
Locus Biosciences initiates world’s first controlled clinical trial for a CRISPR enhanced bacteriophage therapy
Clinical & Manufacturing

Locus Biosciences initiates world’s first controlled clinical trial for a CRISPR enhanced bacteriophage therapy

JAN 9, 2020